PlainBillCongress, translated.Legislation. Context. Public interest.Referred to the Subcommittee on Health.
Congressional Research Service
Version 00 · Introduced in House · Jun 30, 2005
Dietary Supplement Access and Awareness Act - Amends the Federal Food, Drug, and Cosmetic Act to require manufacturers and processors of dietary supplements to report certain information to the Secretary of Health and Human Services annually, including a list of supplements manufactured and the labeling and major ingredients for such supplements.
Requires manufacturers and distributors to report to the Secretary any serious adverse experiences regarding a supplement.
Authorizes the Secretary to require a manufacturer to: (1) conduct postmarket surveillance if there is a reasonable possibility of a supplement causing adverse health consequences; and (2) demonstrate that a supplement is not adulterated.
Showing the opening paragraphs of the official summary.
Requires the Secretary to establish criteria for making a determination that a dietary supplement may pose a significant risk to minors. Deems the act of selling a dietary supplement to a minor after the Secretary has made such a determination to be an act which results in a supplement being misbranded while held for sale.
Deems a dietary supplement to be adulterated if the manufacturer fails to comply with the Secretary's order to demonstrate the drug's safety.
Requires the Secretary to consider a dietary supplement or ingredient as presenting an unreasonable risk of injury or illness if the Secretary determines that the risks of such product outweighs its benefits. Allows the Secretary to consider even a relatively small risk of a serious adverse health effect to be unreasonable.
Directs the Secretary, acting through the Commissioner of Food and Drugs, to carry out dietary supplement education programs for health care professionals and consumers.
People & committees
Rep. Davis, Susan A. [D-CA-53] · D–CA
Legislative record
A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Introduced in House
Primary sources
Text links open the official source. We currently store references to these documents.
No related bills are listed in this snapshot. This does not establish whether the proposal has appeared in earlier Congresses.
Source last updated: Aug 15, 2025. Consult Congress.gov for the current record.
AI Conversation Starters
Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.
Analyze H.R.3156 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.
Examine H.R.3156 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.
Examine H.R.3156 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.
Examine H.R.3156 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.